Here you will find our latest and archived news science 2009 in chronologically order as well as scientific publications.
For all media enquieries please contact Katja Woestenhemke (see contact details on the right).
++ Latest news ++
29.04.2013
AiCuris gewinnt ALLICENSETM 2013 Breakthrough Alliance Award
10.03.2013
AiCuris nominated for: Deloitte Recap ALLICENSE 2013 "Breakthrough Alliance Award"
Voting closed
29.01.2013
AiCuris Surpasses 50% Enrollment Milestone in Phase II Superiority Trial for Herpes Drug Pritelivir
07.11.2012
After license deal for letermovir: Head-to-head phase 2 trial initiated by AiCuris to demonstrate superiority of its novel drug pritelivir vs. valacyclovir for treatment of genital herpes
15.10.2012
AiCuris and Merck Enter Exclusive Worldwide License Agreement for Investigational Portfolio Targeting Human Cytomegalovirus
23.08.2012
AiCuris promising drugs against Herpes simplex (AIC316) and Human Cytomegalovirus (Letermovir, AIC246) in preparation for phase III:
Key note at International Herpesvirus Workshop Calgary, Canada
27.06.2012
Thomas Goldner gets Philipp Klee Price for his publication "The Novel Anticytomegalovirus Compound AIC246 (Letermovir) Inhibits Human Cytomegalovirus Replication through a Specific Antiviral Mechanism That Involves the Viral Terminase."
